Company intelligence / Profile preview

Chemport

Naju, Jeollanam-do, South Koreachemport.eu ↗

Ownership: Private
Development stage: Other

Overview

Chemport is one of the few global suppliers of FDA-approved prescribed fish oil drugs, including Lovaza, Omacor, and Vascepa. The company produces highly purified EPA/DHA blends up to pharmaceutical standards.

Therapeutic areas: Metabolic DisordersCardiovascular
Modalities: Small moleculeBiologicNatural extractFish oil derivative
Industry: Contract Manufacturing Organization

Partnerships

Supplies APIs globally for branded prescription drugs such as Lovaza/Omacor/Vascepa

Beyond the preview

Go deeper on Chemport.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemport.

Explore the full profile